American Healthcare REIT (NYSE:AHR) Issues Quarterly Earnings Results, Misses Expectations By $0.35 EPS

American Healthcare REIT (NYSE:AHR) issued its earnings results on Tuesday. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.35), Zacks reports. The business had revenue of $523.81 million during the quarter, compared to the consensus estimate of $474.26 million. American Healthcare REIT had a negative return on equity of 1.96% and a negative net margin of 1.84%. The company’s quarterly revenue was up 12.8% compared to the same quarter last year. American Healthcare REIT updated its FY24 guidance to $1.40-1.43 EPS and its FY 2024 guidance to 1.400-1.430 EPS.

American Healthcare REIT Price Performance

Shares of AHR stock traded up $0.05 during trading on Thursday, hitting $26.85. The company had a trading volume of 136,293 shares, compared to its average volume of 1,447,901. The stock’s 50-day moving average is $25.16 and its two-hundred day moving average is $19.21. The stock has a market capitalization of $3.53 billion and a price-to-earnings ratio of -55.84. The company has a quick ratio of 0.29, a current ratio of 0.29 and a debt-to-equity ratio of 0.60. American Healthcare REIT has a 52 week low of $12.63 and a 52 week high of $27.77.

American Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 18th. Stockholders of record on Friday, September 20th were given a dividend of $0.25 per share. The ex-dividend date was Friday, September 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.72%. American Healthcare REIT’s dividend payout ratio (DPR) is presently -208.33%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on AHR shares. Bank of America raised their target price on American Healthcare REIT from $27.00 to $31.00 and gave the company a “buy” rating in a research note on Tuesday, September 24th. Truist Financial lifted their price target on American Healthcare REIT from $22.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, September 20th. KeyCorp increased their price objective on American Healthcare REIT from $16.00 to $27.00 and gave the stock an “overweight” rating in a research note on Monday, September 16th. JMP Securities upped their target price on shares of American Healthcare REIT from $18.00 to $30.00 and gave the stock a “market outperform” rating in a research note on Friday, September 20th. Finally, Colliers Securities raised shares of American Healthcare REIT from a “hold” rating to a “moderate buy” rating in a report on Sunday, October 13th. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, American Healthcare REIT has an average rating of “Moderate Buy” and a consensus price target of $23.00.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.